Cover Story

Over the last decade, several studies in humans have found that high-intensity interval training (HIIT), an exercise training program involving brief bouts of intense exercise (90-100% of VO2 max) followed by periods of recovery, can elicit similar metabolic adaptations to classical endurance exercise training but with a much shorter time commitment. Importantly, recent studies have established that HIIT can lower blood glucose and markers of insulin resistance independently of alterations in adiposity/body mass in individuals with insulin resistance and type 2 diabetes.

Marcinko and colleagues show that HIIT leads to a substantial improvement in exercise capacity without altering body mass or adiposity and that this is accompanied by significant reductions in fasting and fed blood glucose levels. HIIT improves adipose tissue insulin sensitivity independently of adipocyte cell size, macrophage accumulation in adipose tissue, adipose tissue inflammation or markers of adipose tissue browning. It also improves liver insulin sensitivity independently of reductions in liver triacylglycerol/diacylglycerol/ceramide levels. Improvements in adipose and liver insulin sensitivity occur independently of acetyl-CoA carboxylase (ACC) phosphorylation, which the authors have previously shown is required for the insulin sensitizing effects of metformin. These findings indicate that HIIT can uncouple inflammation and lipid metabolism from insulin sensitivity and does not depend on AMP-activated protein kinase (AMPK) phosphorylation and inhibition of ACC.

Full Text
The 60 Second Metabolist
In this section authors briefly report on their work recently published in Molecular Metabolism.

Watch the most recent interview by clicking the video still. The link "referring article" directs you to this author's publication.

Amna Khamis
University of Lille, CNRS, Institute Pasteur de Lille, Lille, France
Referring article

Other Scientists...
Issue Alert
If you want to be alerted via email when new content that matches your interests is available, please login or register at
Conferences & Events
June 30 −
July 1
ATLAS Symposium 2019
Middelfart, Denmark
25 − 30
Epigenomics, Nuclear Receptors and Disease
Spetses Island, Greece
9 − 12
Ageing and Regeneration
Innsbruck, Austria
23 − 25
7th Helmholtz Diabetes Conference
Munich, Germany
15 − 18
Nature Conference: Advances in Metabolic Communication
Rio de Janeiro, Brasil
15 − 18
13th European Nutrition Conference
Dublin, Ireland
27 − 31
Metabolism in Action
Hillerod, Denmark
6 − 8
Cachexia, Sarcopenia and Muscle Wasting
Berlin, Germany
Media Coverage
Supported by